Impax Asset Management Group PLC Coherus Bio Sciences, Inc. Transaction History

Impax Asset Management Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$12.95 - $15.41 $4.73 Million - $5.63 Million	-365,248 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $4.47 Million - $6.63 Million	-309,752 Reduced 45.89%	365,248 $5.34 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $435,250 - $497,250	25,000 Added 3.85%	675,000 $12.4 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $1.8 Million - $2.4 Million	125,000 Added 23.81%	650,000 $11.6 Million
Q4 2019 Feb 13, 2020	BUY	$16.33 - $21.37 $8.57 Million - $11.2 Million	525,000 New	525,000 $9.45 Million

130

67.8M

1.68M

91.8K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $65.3M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.